Prodrug-based combinational nanomedicine remodels lipid metabolism for reinforced ferroptosis and immune activation
Ferroptosis is a form of programmed cell death characterized by overwhelmed lipid oxidation, and it has emerged as a promising strategy for cancer therapy. Enhanced ferroptosis could overcome the limitations of conventional therapeutic modalities, particularly in difficult-to-treat tumors. In this s...
Saved in:
| Main Authors: | Ling Lin, Zaixiang Fang, Guohao Liu, Yiwei Liu, Zhiqian Li, Dayi Pan, Yunkun Li, Hemi Kang, Xiaoding Shen, Jingyao Zhang, Qiyong Gong, Kui Luo, Jing Jing |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Acta Pharmaceutica Sinica B |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383525001534 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting the interplay of cGAS-STING and ferroptosis by nanomedicine in the treatment of cancer
by: Chunfei Li, et al.
Published: (2025-08-01) -
From mechanism to application: programmed cell death pathways in nanomedicine-driven cancer therapies
by: Zhan Zhang, et al.
Published: (2025-10-01) -
A novel nanomedicine for osteosarcoma treatment: triggering ferroptosis through GSH depletion and inhibition for enhanced synergistic PDT/PTT therapy
by: Tangbing Xu, et al.
Published: (2025-04-01) -
Creation of anthracycline prodrug
by: A. N. Tevyashova
Published: (2014-12-01) -
Recent progress in stimuli‐activable metallo‐prodrugs for cancer therapy
by: Jinzhe Liang, et al.
Published: (2024-09-01)